The article highlights the disparity in access to the life-extending drug Enhertu for patients with metastatic breast cancer in the UK compared to Scotland and 26 European countries.

Kathryn Hulland, a 47-year-old mother from Devon, has been battling incurable breast cancer since 2019 and is now facing the challenge of a treatment that could extend her life but remains unavailable on the NHS.

Breast Cancer Now and other charities have called for urgent action to secure NHS funding for Enhertu, citing a postcode lottery in cancer care that has led to preventable deaths.

Clinical trials show Enhertu can extend survival by over a year compared to chemotherapy, yet NHS England and Nice have delayed approval due to cost concerns.A recent poll reveals widespread public support for making the drug available, with 82% of UK adults urging its NHS access.The charity emphasizes the urgency, as patients are losing precious time with families while waiting for treatment decisions.